The hyperglycaemic effect is dose-dependent and typically most pronounced in the afternoon and evening, several hours after morning prednisolone administration
A reliable AI workflow needs to preserve context: brand versus molecule : Ozempic and Wegovy are both semaglutide, but not the same market object single versus dual agonist : tirzepatide is not simply another semaglutide brand indication : diabetes, obesity, and cardiovascular risk reduction are different analytic frames funding status : PBS and private-pay populations can behave very differently time period : a 2023 shortage-period record is not equivalent to a 2026 post-shortage record source type : TGA, PBS, PBAC, company releases, media reporting, and clinical trials have different evidentiary roles The main AI risk is not that a model cannot summarise GLP-1 information
Side effects are a major hurdle
Coverage for GLP-1 weight loss medications varies across Anthem Blue Cross Blue Shield plan types in Virginia and often depends on whether your employer group elected to include obesity medication coverage
Structure insights into selective coupling of G protein subtypes by a class B G protein-coupled receptor
Bairoch, A